Title : Somatostatin Receptor Expression in GH-Secreting Pituitary Adenomas Treated with Long-Acting Somatostatin Analogues in Combination with Pegvisomant.

Pub. Date : 2017

PMID : 27455094






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Additionally, we evaluated the required PEGV dose to achieve insulin-like growth factor I (IGF-I) normalization in relation to the SSTR expression. pegvisomant insulin like growth factor 1 Homo sapiens
2 Additionally, we evaluated the required PEGV dose to achieve insulin-like growth factor I (IGF-I) normalization in relation to the SSTR expression. pegvisomant insulin like growth factor 1 Homo sapiens
3 Noteworthy, SSTR2 expression in naive somatotroph adenoma tissues was inversely correlated with the required PEGV dose to achieve IGF-I normalization during postsurgical medical treatment (rho = -0.538, p = 0.024). pegvisomant insulin like growth factor 1 Homo sapiens
4 Additionally, the SSTR2 expression in treatment-naive somatotroph adenoma tissues was inversely correlated with the required PEGV dose to achieve IGF-I normalization. pegvisomant insulin like growth factor 1 Homo sapiens